Tower Research Capital (TRC)’s ASP Isotopes ASPI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$73.3K Buy
16,578
+14,951
+919% +$88.4K ﹤0.01% 2434
2025
Q4
$8.7K Sell
1,627
-23,576
-94% -$188K ﹤0.01% 3937
2025
Q3
$242K Buy
25,203
+14,313
+131% +$132K 0.01% 1327
2025
Q2
$80.2K Buy
10,890
+5,353
+97% +$35.9K ﹤0.01% 2562
2025
Q1
$26K Buy
5,537
+1,262
+30% +$6.3K ﹤0.01% 2730
2024
Q4
$19.4K Buy
4,275
+447
+12% +$2.38K ﹤0.01% 3208
2024
Q3
$10.6K Buy
+3,828
New +$10.2K ﹤0.01% 3733
2024
Q2
Sell
-11,434
Closed -$47.2K 5676
2024
Q1
$47.2K Buy
11,434
+5,802
+103% +$17.9K ﹤0.01% 2320
2023
Q4
$10.1K Sell
5,632
-6,192
-52% -$9.03K ﹤0.01% 4296
2023
Q3
$11.2K Buy
+11,824
New +$12.2K ﹤0.01% 4017

Other funds holding ASPI

Tower Research Capital (TRC)'s ASPI Position: Q1 2026 in Review

Tower Research Capital (TRC) increased its ASP Isotopes (ASPI) stake by 919% in Q1 2026, buying an estimated $88.4K and bringing the position to 16,578 shares worth $73.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2434.

Tower Research Capital (TRC) first reported a position in ASPI in Q3 2023 and has held it in 10 quarters since. The position peaked at $242K in Q3 2025. 177 funds tracked by Wall St. Rank hold ASPI as of Q1 2026.

  • Tower Research Capital (TRC) held 16,578 shares of ASP Isotopes worth $73.3K as of Q1 2026.
  • Tower Research Capital (TRC) bought 14,951 ASP Isotopes shares in Q1 2026, an estimated $88.4K.
  • ASP Isotopes made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #2434 holding.
  • Tower Research Capital (TRC) first reported a position in ASP Isotopes in Q3 2023 and has held it in 10 quarters since.
  • Tower Research Capital (TRC)'s ASP Isotopes position peaked at $242K in Q3 2025.
  • 177 funds tracked by Wall St. Rank held ASP Isotopes as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.